文献速递妇产影像儿科影像US

双绒毛膜双羊膜囊双胎妊娠选择性胎儿生长受限:妊娠与围产结局的系统评价与Meta分析

Selective fetal growth restriction in dichorionic diamniotic twin pregnancy: systematic review and meta-analysis of pregnancy and perinatal outcomes.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-11

本系统评价与Meta分析纳入13项研究、1339例合并选择性胎儿生长受限(sFGR)的双绒毛膜双羊膜囊(DCDA)双胎妊娠和6316例无sFGR的DCDA双胎妊娠,评估其妊娠与围产结局。结果显示sFGR组宫内死亡、围产期死亡、34周前早产、复合新生儿病率及NICU入住风险均高于无sFGR组,但34周前早产和子痫前期/妊娠期高血压风险无显著差异。作者认为DCDA双胎合并sFGR围产病率与死亡率高,咨询和处理时应使用双胎特异性而非单胎结局数据。

要点

  • DCDA双胎合并sFGR的宫内死亡风险显著高于无sFGR者(OR 5.2,95%CI 3.2-8.6)。
  • sFGR组复合新生儿病率或NICU入住风险显著高于无sFGR组(OR 3.2,95%CI 1.9-5.6)。
  • 双胎对内比较:生长受限胎儿围产期死亡OR 2.1(95%CI 1.0-4.1),复合病率OR 1.9(95%CI 1.7-3.1)。

核心结论

  • DCDA双胎妊娠合并sFGR围产病率与死亡率高,咨询和处理时应使用双胎特异性而非单胎结局数据。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、EMBASE和Cochrane Library数据库,纳入13项研究,共1339例合并sFGR的DCDA双胎妊娠和6316例无sFGR的DCDA双胎妊娠。
  • 采用随机效应Meta分析,结果以合并比例或比值比(OR)及95%CI报告。

诊断标准与关键数值

  • sFGR组胎儿宫内死亡2.6%(95%CI 1.1-4.7%),无sFGR组0.6%(95%CI 0.3-9.7%)。
  • sFGR组围产期死亡5.2%(95%CI 3.5-7.3%),无sFGR组1.7%(95%CI 0.1-5.7%)。
  • sFGR组37周前早产84.1%(95%CI 55.6-99.2%),无sFGR组69.1%(95%CI 45.4-88.4%)。
  • sFGR组34、32、28周前早产分别为18.4%(95%CI 4.4-38.9%)、13.0%(95%CI 9.5-17.1%)、1.5%(95%CI 0.6-2.3%);无sFGR组分别为10.2%(95%CI 3.1-20.7%)、7.8%(95%CI 6.8-9.0%)、1.8%(95%CI 1.3-2.4%)。
  • 双胎对内比较:生长受限胎儿复合病率39.0%(95%CI 11.1-71.5%)vs 适龄胎儿29.9%(95%CI 3.5-65.0%),OR 1.9(95%CI 1.7-3.1);围产期死亡3.0%(95%CI 1.8-4.5%)vs 1.6%(95%CI 0.9-2.6%),OR 2.1(95%CI 1.0-4.1)。

临床应用与阅片要点

  • sFGR组子痫前期或妊娠期高血压19.9%(95%CI 12.4-28.6%),无sFGR组12.8%(95%CI 10.4-15.4%)。
  • sFGR组复合新生儿病率28.2%(95%CI 7.8-55.1%),无sFGR组13.9%(95%CI 6.5-23.5%)。
  • sFGR组较无sFGR组宫内死亡OR 5.2(95%CI 3.2-8.6),复合病率或NICU入住OR 3.2(95%CI 1.9-5.6)。
  • sFGR组与无sFGR组34周前早产风险无显著差异(P=0.220),子痫前期/妊娠期高血压风险无显著差异(P=0.210)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Most of the published literature on selective fetal growth restriction (sFGR) has focused on monochorionic twin pregnancies. The aim of this systematic review was to report on the outcome of dichorionic diamniotic (DCDA) twin pregnancies complicated by sFGR.

METHODS: MEDLINE, EMBASE and The Cochrane Library databases were searched. The inclusion criteria were DCDA twin pregnancies complicated by sFGR. The outcomes explored were intrauterine death (IUD), neonatal death and perinatal death (PND), survival of at least one and both twins, preterm birth (PTB) (either spontaneous or iatrogenic) prior to 37, 34, 32 and 28 weeks' gestation, pre-eclampsia (PE) or gestational hypertension, neurological, respiratory and infectious morbidity, Apgar score < 7 at 5 min, necrotizing enterocolitis, retinopathy of prematurity and admission to the neonatal intensive care unit (NICU). A composite outcome of neonatal morbidity, defined as the occurrence of respiratory, neurological or infectious morbidity, was also evaluated. Random-effects meta-analysis was used to analyze the data, and results are reported as pooled proportion or odds ratio (OR) with 95% CI.

RESULTS: Thirteen studies reporting on 1339 pregnancies with sFGR and 6316 pregnancies without sFGR were included. IUD occurred in 2.6% (95% CI, 1.1-4.7%) of fetuses from DCDA pregnancies with sFGR and 0.6% (95% CI, 0.3-9.7%) of those from DCDA pregnancies without sFGR, while the respective values for PND were 5.2% (95% CI, 3.5-7.3%) and 1.7% (95% CI, 0.1-5.7%). Spontaneous or iatrogenic PTB before 37 weeks complicated 84.1% (95% CI, 55.6-99.2%) of pregnancies with sFGR and 69.1% (95% CI, 45.4-88.4%) of those without sFGR. The respective values for PTB before 34, 32 and 28 weeks were 18.4% (95% CI, 4.4-38.9%), 13.0% (95% CI, 9.5-17.1%) and 1.5% (95% CI, 0.6-2.3%) in pregnancies with sFGR and 10.2% (95% CI, 3.1-20.7%), 7.8% (95% CI, 6.8-9.0%) and 1.8% (95% CI, 1.3-2.4%) in those without sFGR. PE or gestational hypertension complicated 19.9% (95% CI, 12.4-28.6%) of pregnancies with sFGR and 12.8% (95% CI, 10.4-15.4%) of those without sFGR. Composite morbidity occurred in 28.2% (95% CI, 7.8-55.1%) of fetuses from pregnancies with sFGR and 13.9% (95% CI, 6.5-23.5%) of those from pregnancies without sFGR. When stratified according to the sFGR status within a twin pair, composite morbidity occurred in 39.0% (95% CI, 11.1-71.5%) of growth-restricted fetuses and 29.9% (95% CI, 3.5-65.0%) of appropriately grown fetuses (OR, 1.9 (95% CI, 1.7-3.1)), while the respective values for PND were 3.0% (95% CI, 1.8-4.5%) and 1.6% (95% CI, 0.9-2.6%) (OR, 2.1 (95% CI, 1.0-4.1)). On risk analysis, DCDA pregnancies complicated by sFGR had a significantly higher risk of IUD (OR, 5.2 (95% CI, 3.2-8.6)) and composite morbidity or admission to the NICU (OR, 3.2 (95% CI, 1.9-5.6)) compared to those without sFGR, while there was no difference in the risk of PTB before 34 weeks (P = 0.220) or PE/gestational hypertension (P = 0.210).

CONCLUSIONS: DCDA twin pregnancies complicated by sFGR are at high risk of perinatal morbidity and mortality. The findings of this systematic review are relevant for counseling and management of complicated DCDA twin pregnancies, in which twin-specific, rather than singleton, outcome data should be used. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. D'antonio F, Prasad S, Masciullo L, et al. Selective fetal growth restriction in dichorionic diamniotic twin pregnancy: systematic review and meta-analysis of pregnancy and perinatal outcomes. Ultrasound Obstet Gynecol. 2024. PMID: 37519089. doi:10.1002/uog.26302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。